METTL14 and colorectal carcinoma: For instance, the low expression of METTL14 in CRC enhances the stability of pri-miR-17 mRNA and increases the expression of miR-17-5p in an m6 A-dependent manner, inducing chemotherapy resistance to 5-FU [258].